Skip to main content

Poster Presentation: Exosome Based Multiomics Combined with cfDNA Methylation Reveals Complementary Signatures in Blood Based Liquid Biopsy that Carry Promise for Minimally Invasive Colorectal Cancer Screening

Scientific Meeting Posters

Colorectal cancer (CRC) ranks second in cancer morbidity, with approximately 60% of patients being diagnosed at an advanced stage. Here, we apply a multiomic strategy jointly leveraging plasma cell-free DNA (cfDNA) and multiple extracellular vesicle (EV)-derived analytes to enhance CRC diagnostic accuracy.

Exosome-based multiomics combined with cfDNA methylation reveals complementary signatures in blood-based liquid biopsy that carry promise for minimally invasive colorectal cancer screening